Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

21,338 total articles

Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
May 19, 2026
Maya Rios
Press Releases

Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Cullinan Therapeutics announced that the FDA has granted Orphan Drug Designation to CLN-049, a novel FLT3xCD3 T cell engager under investigation for treating relapsed/refractory acute myeloid leukemia (AML). The designation supports the drug's potential to address significant unmet medical needs in AML, including in patients with poor prognosis due…

CGEM
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
May 19, 2026
Priya Menon
Press Releases

Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Korro Bio announced the selection of KRRO-111, a proprietary GalNAc-conjugated oligonucleotide therapeutic, as a development candidate for treating Alpha-1 Antitrypsin Deficiency (AATD). KRRO-111 leverages the company's OPERA RNA editing platform to correct the pathogenic mutation in the SERPINA1 gene, achieving over 90% editing efficiency and sign…

KRRO
Ambow Education Holding Ltd. (NYSE American: AMBO) Launches HybriU Collaboration Board, Bringing One-Scan Real-Time Collaboration to Meetings, Classrooms, Workshops, and Live Events
May 19, 2026
Hana Yamamoto
Press Releases

Ambow Education Holding Ltd. (NYSE American: AMBO) Launches HybriU Collaboration Board, Bringing One-Scan Real-Time Collaboration to Meetings, Classrooms, Workshops, and Live Events

Ambow Education Holding Ltd. (NYSE American: AMBO) has launched the HybriU Collaboration Board, an AI-powered phygital tool providing real-time collaborative whiteboard access via a single QR code. This innovation enables participants to interact with various content types without software installation or accounts, aiming to enhance hybrid collabor…

AMBO
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
May 19, 2026
Nina Shah
Press Releases

OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD

OKYO Pharma Limited appoints international expert Dr. Marta Sacchetti, MD, PhD, to its Scientific Advisory Board. This strategic addition strengthens the company's expertise in neuro-inflammatory corneal diseases, aligning with its development of urcosimod, a promising investigational therapy for neuropathic corneal pain (NCP). Having completed a s…

OKYO
Osisko Development Appoints Vice President, Sustainable Development
May 19, 2026
Avery Klein
Press Releases

Osisko Development Appoints Vice President, Sustainable Development

Osisko Development Corp. has appointed Greg Perrins as Vice President of Sustainable Development to enhance its approach to Indigenous relations and public sector engagement in British Columbia. Perrins brings over 15 years of experience in natural resource sectors and government roles, aiming to support the company’s flagship Cariboo Gold Project …

ODV
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
May 19, 2026
Sofia Navarro
Press Releases

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced updated positive clinical data from its ongoing Expanded Access Program evaluating intranasal foralumab in 14 patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). The data showed intranasal foralumab was well tolerated with no new safety signals, demonstrated trends toward …

TLSA
Quantum Cyber Files Patent with USPTO for Autonomous Naval Mine Countermeasure System Addressing Iran's Mining of the Strait of Hormuz and Trump Administration Homeland Security Priorities
May 19, 2026
Sofia Navarro
Press Releases

Quantum Cyber Files Patent with USPTO for Autonomous Naval Mine Countermeasure System Addressing Iran's Mining of the Strait of Hormuz and Trump Administration Homeland Security Priorities

Quantum Cyber N.V. announced the filing of a provisional patent application with the USPTO for an autonomous naval mine countermeasure system designed to detect and neutralize underwater mines using unmanned aerial vehicles. The technology is timely and directly addresses a current military crisis in the Strait of Hormuz where Iran has deployed nav…

QUCY
EyePoint Announces Participation at Upcoming Investor Conferences
May 19, 2026
Hana Yamamoto
Press Releases

EyePoint Announces Participation at Upcoming Investor Conferences

EyePoint, Inc., a clinical-stage biopharmaceutical company focused on innovative therapeutics for serious retinal diseases, announced its participation in several upcoming investor conferences including Stifel, Jefferies, and Goldman Sachs. The company highlighted its lead product candidate, DURAVYU™, a sustained delivery treatment undergoing Phase…

EYPT
Orion Announces Preliminary FY26 Revenue of $86M and Approximately $2M Adjusted EBITDA; Reiterates Expectations for Increased Growth and Profitability in FY 2027
May 19, 2026
Sofia Navarro
Press Releases

Orion Announces Preliminary FY26 Revenue of $86M and Approximately $2M Adjusted EBITDA; Reiterates Expectations for Increased Growth and Profitability in FY 2027

Orion Energy Systems announced preliminary unaudited results for fiscal year 2026, posting $86 million in revenue and adjusted EBITDA of at least $2 million, marking six consecutive quarters of positive adjusted EBITDA. The company reiterated fiscal year 2027 guidance with projected revenues between $95 million and $97 million and positive adjusted…

OESX
Tecnoglass Announces Upcoming Investor Conferences
May 19, 2026
Avery Klein
Press Releases

Tecnoglass Announces Upcoming Investor Conferences

Tecnoglass, a leading producer of high-end aluminum and vinyl windows and architectural glass, announced attendance at three major investor conferences in May and June 2026. The company highlights its strong presence in the U.S. market, accounting for 95% of its revenues, and its significant manufacturing footprint in Colombia.

TGLS
XORTX Announces Closing of US$5 Million Public Offering
May 19, 2026
Maya Rios
Press Releases

XORTX Announces Closing of US$5 Million Public Offering

XORTX Therapeutics Inc., a clinical-stage pharmaceutical company specializing in therapies for gout and kidney diseases, has completed a $5 million public offering through issuing common shares and pre-funded warrants. The proceeds will support working capital, corporate purposes, and investor relations activities. The offering was made under an SE…

XRTX
Bowman Selected to Lead Waterside Infrastructure Design for PhilaPort’s $50 Million Cruise Terminal Capital Program
May 19, 2026
Priya Menon
Press Releases

Bowman Selected to Lead Waterside Infrastructure Design for PhilaPort’s $50 Million Cruise Terminal Capital Program

Bowman Consulting Group Ltd. has been selected to lead the waterside design, permitting, and construction-phase services for the development of a cruise terminal facility at the Port of Philadelphia. This project is a key part of PhilaPort's $50 million capital initiative aimed at converting an existing wharf into a temporary terminal to accommodat…

BWMN
Parsons Celebrates the Opening of D Line Subway Extension Section 1
May 19, 2026
Ajmal Hussain
Press Releases

Parsons Celebrates the Opening of D Line Subway Extension Section 1

Parsons Corporation announced the opening of Section 1 of the D Line Subway Extension in Los Angeles, marking completion of 3.9 miles of new subway track with three underground stations from Wilshire/Western to Beverly Hills. Parsons was the lead designer and managed the final design for this project segment, aimed at improving commuter access, red…

PSN
Hotel101 Global Reaches Record Single-Day Revenue Generation at 100% Occupancy in Hotel101 Madrid
May 19, 2026
Ajmal Hussain
Press Releases

Hotel101 Global Reaches Record Single-Day Revenue Generation at 100% Occupancy in Hotel101 Madrid

Hotel101 Global Holdings Corp., trading as HBNB on NASDAQ, reported that its 680-room Hotel101-Madrid property generated more than €100,000 in recurring room revenues in a single day at 100% occupancy. The Madrid hotel, serving as the company's global prototype, underscores strong demand and validates its asset-light, prop-tech hospitality model. T…

HBNB
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
May 19, 2026
Caleb Monroe
Press Releases

Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies

Relay Therapeutics announced initial Phase 2 clinical data from their ReInspire trial evaluating Zovegalisib, a selective PI3Kα inhibitor, in patients with PIK3CA-driven vascular anomalies. The data show a 60% volumetric response rate at 12 weeks with symptomatic improvements reported by both patients and investigators. The safety profile supports …

RLAY
Bilibili Inc. Announces First Quarter 2026 Financial Results
May 19, 2026
Sofia Navarro
Press Releases

Bilibili Inc. Announces First Quarter 2026 Financial Results

Bilibili Inc. announced its Q1 2026 financial results showing a 7% year-over-year increase in total net revenues to RMB7.47 billion (US$1.08 billion) and a net profit of RMB202 million compared to a net loss in Q1 2025. Key growth drivers include an 8% increase in daily active users to 115 million, 30% growth in advertising revenues aided by improv…

BILI
Clearmind Medicine Announces 1-for-10 Reverse Share Split
May 19, 2026
Ajmal Hussain
Press Releases

Clearmind Medicine Announces 1-for-10 Reverse Share Split

Clearmind Medicine Inc., a clinical-stage biotech firm focused on non-hallucinogenic neuroplastogen-derived therapeutics, announced a 1-for-10 reverse share split effective May 21, 2026. This move aims to regain compliance with Nasdaq's Minimum Bid Price Rule. The reverse split will reduce outstanding common shares from approximately 10.2 million t…

CMND